Novartis India Limited Recommends Dividend for the Year Ended March 31, 2019; Announces Executive Changes, Effect from June 1, 2019
The board also approved the appointment of Mr. Felix Doss as the Chief Financial Officer of the Company with effect from June 1, 2019. Prior to joining Novartis in Mumbai, Felix was with Alcon Laboratories in Bangalore as Finance director since 2005 leading team of over 20 associates across multiple functions including IT, supply chain, legal and finance and was instrumental in integrating functions with core business for strategic alliance and stable growth. Consequent to the elevation of Ms. Monaz Noble, Whole time Director and Chief Financial Officer with Novartis Group, Ms. Noble would relinquish her executive responsibilities in the Company by the close of business hours on May 31, 2019. However, Ms. Noble would continue to be on the Board of the Company in the capacity of a Non-Executive, Non-Independent Director effective June 1, 2019.